Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    gynecology | NICHD
Show Display Options
Rank Status Study
21 Completed Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission
Condition: HIV Infections
Interventions: Procedure: Intrapartum HIV counseling/testing;   Procedure: Postpartum HIV counseling/testing
22 Recruiting Prenatal Microarray Follow-Up Study
Condition: Genetic Diseases
Intervention: Other: 3-year follow-up
23 Completed Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning
Conditions: Endometriosis;   Stem Cell Transplant;   Healthy Volunteers
Intervention:
24 Active, not recruiting Combined Treatment for Mixed Incontinence
Conditions: Urinary Incontinence, Stress;   Urinary Incontinence, Urge
Interventions: Procedure: Miduretheral Sling;   Other: Miduretheral Sling with behavioral/pelvic floor therapy
25 Completed Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
Condition: HIV Infections
Interventions: Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate
26 Completed Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Conditions: HIV Infections;   Pregnancy Complications, Infectious
Intervention: Behavioral: Adherence assessment
27 Completed Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery
Condition: HIV Infections
Intervention: Drug: Tenofovir 1% vaginal gel
28 Completed Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)
Condition: Urinary Incontinence, Urge
Interventions: Device: InterStim® device;   Drug: Botox® injection
29 Completed Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV vCP1521;   Biological: ALVAC HIV-1 vCP1521
30 Completed Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Conditions: Pregnancy;   Pregnancy Complications
Intervention:
31 Completed
Has Results
PREGNANT Short Cervix Trial
Conditions: Preterm Delivery;   Short Cervix;   Short Uterine Cervical Length
Interventions: Drug: progesterone;   Drug: placebo
32 Completed Effects of a Kappa Agonist on Hot Flashes in Menopausal Women
Condition: Treatment of Menopausal Hot Flashes
Interventions: Drug: Standard Dose Kappa Agonist;   Drug: Half Dose Kappa Agonist;   Other: Placebo
33 Completed Safety and Acceptability of a Vaginal Microbicide
Conditions: HIV Infections;   Hepatitis B, Chronic
Intervention: Drug: 1% tenofovir gel
34 Unknown  Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol
Condition: Contraception
Intervention: Drug: NES/EE CVR
35 Completed
Has Results
Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Nevirapine placebo
36 Completed BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women
Condition: HIV Infections
Interventions: Drug: BufferGel;   Drug: PRO 2000/5 Gel;   Drug: Placebo gel

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Study has passed its completion date and status has not been verified in more than two years.